Study registration: *
Publication Chung H, BMJ, 2021
Dates: 2020-12-14 to 2020-12-19
Funding: Public/non profit (Canadian Immunization Research Network (CIRN) through a grant from the Public Health Agency of Canada and the Canadian Institutes of Health Research; the Public Health Agency of Canada, through the Vaccine Surveillance Reference group and the COVID-19 Immunity Task Force; ICES, which is funded by an annual grant from Ontario’s Ministry of Health (MOH) and Ministry of Long term Care (MLTC); the Ontario Health Data Platform (OHDP), a Province of Ontario initiative to support Ontario’s ongoing response to covid-19 and its related impacts.)
Conflict of interest: Yes (KW is chief executive officer of CANImmunize and serves on the data safety board for the Medicago covid-19 vaccine trial. SMM has received unrestricted research grants from Merck, GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Roche-Assurex for unrelated studies. SMM has received fees as an advisory board member for GlaxoSmithKline, Merck, Pfizer, Sanofi Pasteur, and Seqirus. CHR has received an unrestricted research grant from Pfizer for an unrelated study.)